{"article":{"annotation":{"article_id":"gsk-third-quarter-sales-total-core-profit-currency-2026","available_at":"2026-10-28T19:46:27.657949Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"f74f4ebabc1c55a6bdf205ca051e5542fc372efcee5987da21874f9e6d3749a5","input_sha256":"735d074d15bafd9940fbea2ecb92c031ae9d9a9de22c14ee484c8244a6197cd9","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"GB","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"]}],"geometry":null,"id":"iso3166-1:GB","kind":"country-or-area","labels":{"ar":"المملكة المتحدة لبريطانيا العظمى وآيرلندا الشمالية","en":"United Kingdom of Great Britain and Northern Ireland","es":"Reino Unido de Gran Bretaña e Irlanda del Norte","fr":"Royaume-Uni de Grande-Bretagne et d’Irlande du Nord"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000349","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"]}],"method":"controlled-rules-v1","rule_id":"business-broad","status":"candidate"},{"concept_id":"medtop:20000178","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: reported and core operating profit","source_urls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"]}],"method":"controlled-rules-v1","rule_id":"corporate-results","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=de","category":"business","content":{"key_points":[],"paragraphs":["GSK meldete am 28. Oktober für das dritte Quartal einen Umsatz von 8,887 Milliarden Pfund, ein Plus von 4 Prozent zu tatsächlichen Wechselkursen und 5 Prozent zu konstanten Wechselkursen. Der gesamte Betriebsgewinn sank zu tatsächlichen Wechselkursen um 18 Prozent auf 2,127 Milliarden Pfund.","Der bereinigte Betriebsgewinn stieg zu tatsächlichen Wechselkursen um 3 Prozent auf 3,076 Milliarden Pfund beziehungsweise zu konstanten Wechselkursen um 5 Prozent. Das Unternehmen führte die Differenz zwischen Gesamt- und Kernleistung teilweise auf Restrukturierungskosten von 328 Millionen Pfund und geringere sonstige Netto-Betriebserträge zurück. Die Kernzahlen sind Nicht-IFRS-Kennzahlen und ersetzen nicht die ausgewiesenen Ergebnisse.","GSK bestätigte die Jahresprognose für ein Umsatzwachstum von 3 bis 5 Prozent und ein Wachstum des bereinigten Betriebsgewinns von 7 bis 9 Prozent, jeweils zu konstanten Wechselkursen. Dies sind Prognosen. Wechselkursbereinigtes Wachstum, ausgewiesenes Wachstum und die Kernkennzahlen des Unternehmens beruhen auf unterschiedlichen Vergleichen und dürfen nicht zu einer einzigen Gewinnzahl zusammengeführt werden."],"sections":[]},"corrections":[],"country":"GB","data":{"blocks":[{"description":{"ar":"نشر الإعلان الرسمي في 28 أكتوبر 2026.","de":"Veröffentlichung der offiziellen Mitteilung am 28. Oktober 2026.","en":"Publication of the official announcement on 28 October 2026.","es":"Publicación del anuncio oficial el 28 de octubre de 2026.","fr":"Publication de l’annonce officielle le 28 octobre 2026.","pt":"Publicação do anúncio oficial em 28 de outubro de 2026.","tr":"Resmî duyurunun 28 Ekim 2026’da yayımlanması."},"id":"source-announcement","items":[{"date":"2026-10-28","description":{"ar":"أعلنت جي إس كي في 28 أكتوبر عن مبيعات للربع الثالث بلغت 8.887 مليارات جنيه إسترليني، بزيادة 4% بأسعار الصرف الفعلية و5% بأسعار الصرف الثابتة. وانخفض إجمالي الربح التشغيلي 18% بأسعار الصرف الفعلية إلى 2.127 مليار جنيه.","de":"GSK meldete am 28. Oktober für das dritte Quartal einen Umsatz von 8,887 Milliarden Pfund, ein Plus von 4 Prozent zu tatsächlichen Wechselkursen und 5 Prozent zu konstanten Wechselkursen. Der gesamte Betriebsgewinn sank zu tatsächlichen Wechselkursen um 18 Prozent auf 2,127 Milliarden Pfund.","en":"GSK reported third-quarter turnover of 8.887 billion pounds on 28 October, up 4% at actual exchange rates and 5% at constant exchange rates. Total operating profit fell 18% at actual exchange rates to 2.127 billion pounds.","es":"GSK informó el 28 de octubre de una facturación de 8.887 millones de libras en el tercer trimestre, un 4% más a tipos de cambio reales y un 5% a tipos de cambio constantes. El beneficio operativo total cayó un 18% a tipos reales, hasta 2.127 millones de libras.","fr":"GSK a annoncé le 28 octobre un chiffre d’affaires de 8,887 milliards de livres au troisième trimestre, en hausse de 4 % aux taux de change réels et de 5 % à taux de change constants. Le bénéfice opérationnel total a diminué de 18 % aux taux réels, à 2,127 milliards de livres.","pt":"A GSK comunicou em 28 de outubro um volume de negócios de 8,887 mil milhões de libras no terceiro trimestre, mais 4% às taxas de câmbio reais e 5% às taxas constantes. O lucro operacional total caiu 18% às taxas reais, para 2,127 mil milhões de libras.","tr":"GSK, 28 Ekim’de üçüncü çeyrek cirosunu gerçek döviz kurlarıyla %4, sabit döviz kurlarıyla %5 artışla 8,887 milyar sterlin olarak bildirdi. Toplam faaliyet kârı gerçek kurlarla %18 düşerek 2,127 milyar sterline geriledi."},"label":{"ar":"مبيعات جي إس كي ترتفع مع تباين الربح التشغيلي المعلن والأساسي","de":"GSK-Umsatz steigt, während berichteter und bereinigter Betriebsgewinn auseinanderlaufen","en":"GSK sales rise as reported and core operating profit diverge","es":"Las ventas de GSK crecen mientras divergen el beneficio operativo declarado y el básico","fr":"Les ventes de GSK progressent tandis que les bénéfices opérationnels publié et courant divergent","pt":"Vendas da GSK sobem enquanto os lucros operacionais reportado e core divergem","tr":"GSK satışları artarken açıklanan ve temel faaliyet kârı farklı yönlerde seyretti"},"status":"occurred"}],"methodology":{"ar":"يسجل التاريخ نشر المصدر الرسمي المذكور، ولا يثبت اكتمال الإجراءات المستقبلية المعلنة.","de":"Das Datum bezeichnet die Veröffentlichung der genannten offiziellen Quelle. Es belegt nicht, dass angekündigte Maßnahmen abgeschlossen wurden.","en":"The date records publication of the cited official source. It does not establish completion of announced future actions.","es":"La fecha corresponde a la publicación de la fuente oficial citada. No confirma que se hayan completado las acciones anunciadas.","fr":"La date correspond à la publication de la source officielle citée. Elle ne confirme pas la réalisation des actions annoncées.","pt":"A data regista a publicação da fonte oficial citada. Não comprova a conclusão das ações anunciadas.","tr":"Tarih, belirtilen resmî kaynağın yayımlandığı günü gösterir; duyurulan gelecek eylemlerin tamamlandığını kanıtlamaz."},"sourceUrls":["https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"],"title":{"ar":"نشر المصدر الرسمي","de":"Veröffentlichung der offiziellen Quelle","en":"Source publication","es":"Publicación de la fuente oficial","fr":"Publication de la source officielle","pt":"Publicação da fonte oficial","tr":"Resmî kaynağın yayımlanması"},"type":"events","updatedAt":"2026-10-28T19:38:33Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026/data/source-announcement?lang=de&format=csv","json":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026/data/source-announcement?lang=de&format=json"},"id":"source-announcement"}],"data_types":["events"],"editorial_illustration":{"alt":"Konzeptionelle Darstellung von Zusammenhängen zwischen Industrie, Technik und Logistik.","asset_id":"newsverum-v1-business","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"de","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","width":1536}],"width":1536},"event_id":"event-4abb730d-3957-5da7-a65c-e1e7abd6cc06","event_period":"2026-09","event_period_basis":"event-or-reference-period","id":"gsk-third-quarter-sales-total-core-profit-currency-2026","image":null,"importance":0.6,"language":"de","modified_at":"2026-10-28T19:46:24+00:00","publication_basis":"publication-record","published_at":"2026-10-28T19:46:24+00:00","reading_minutes":1,"region":"world","relations":[],"section_illustration":{"alt":"Konzeptionelle Darstellung von Zusammenhängen zwischen Industrie, Technik und Logistik.","asset_id":"newsverum-v1-business","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"de","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/business-1536.webp","width":1536}],"width":1536},"slug":"gsk-third-quarter-sales-total-core-profit-currency-2026","sources":[{"checkedAt":"2026-10-28","name":"GSK","publishedAt":"2026-10-28","url":"https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-q3-performance-and-continued-momentum/"}],"summary":"GSK meldete am 28. Oktober für das dritte Quartal einen Umsatz von 8,887 Milliarden Pfund, ein Plus von 4 Prozent zu tatsächlichen Wechselkursen und 5 Prozent zu konstanten Wechselkursen.","text":"GSK meldete am 28. Oktober für das dritte Quartal einen Umsatz von 8,887 Milliarden Pfund, ein Plus von 4 Prozent zu tatsächlichen Wechselkursen und 5 Prozent zu konstanten Wechselkursen.\n\nGSK meldete am 28. Oktober für das dritte Quartal einen Umsatz von 8,887 Milliarden Pfund, ein Plus von 4 Prozent zu tatsächlichen Wechselkursen und 5 Prozent zu konstanten Wechselkursen. Der gesamte Betriebsgewinn sank zu tatsächlichen Wechselkursen um 18 Prozent auf 2,127 Milliarden Pfund.\n\nDer bereinigte Betriebsgewinn stieg zu tatsächlichen Wechselkursen um 3 Prozent auf 3,076 Milliarden Pfund beziehungsweise zu konstanten Wechselkursen um 5 Prozent. Das Unternehmen führte die Differenz zwischen Gesamt- und Kernleistung teilweise auf Restrukturierungskosten von 328 Millionen Pfund und geringere sonstige Netto-Betriebserträge zurück. Die Kernzahlen sind Nicht-IFRS-Kennzahlen und ersetzen nicht die ausgewiesenen Ergebnisse.\n\nGSK bestätigte die Jahresprognose für ein Umsatzwachstum von 3 bis 5 Prozent und ein Wachstum des bereinigten Betriebsgewinns von 7 bis 9 Prozent, jeweils zu konstanten Wechselkursen. Dies sind Prognosen. Wechselkursbereinigtes Wachstum, ausgewiesenes Wachstum und die Kernkennzahlen des Unternehmens beruhen auf unterschiedlichen Vergleichen und dürfen nicht zu einer einzigen Gewinnzahl zusammengeführt werden.","title":"GSK-Umsatz steigt, während berichteter und bereinigter Betriebsgewinn auseinanderlaufen","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},{"api_url":"https://newsverum.com/api/v1/articles/gsk-third-quarter-sales-total-core-profit-currency-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/gsk-third-quarter-sales-total-core-profit-currency-2026"}],"url":"https://newsverum.com/de/news/gsk-third-quarter-sales-total-core-profit-currency-2026"},"version":"1"}
